Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| YF | YELLOW FEVER (STAMARIL) | SANOFI PASTEUR | 1 | UK134AA | IM / RA |
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
| YF | YELLOW FEVER (YF-VAX) | SANOFI PASTEUR | UNK | — | OT |
yf-vax was administered 2 weeks after another live vaccine (mmr) with no reported ae; Initial information received on 06-May-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves an unknown age male patient to whom YELLOW FEVER VACCINE - [YF-VAX] was administered 2 weeks after another live vaccine (MMR) with no reported ae (adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received YELLOW FEVER VACCINE - Solution for injection (strength, dose, batch and expiry date unknown) via unknown route in unknown administration site for Immunization 2 weeks after another live vaccine (mmr) with no reported ae (inappropriate schedule of product administration) (same day latency). Information on batch number and expiry date corresponding to the one at time of event occurrence was requested. Reportedly, they were not given 4 weeks apart, they were only given 2 weeks apart Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.